Clinical Trial Update: Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether aromatase inhibitors alter intestinal calcium absorption and related bone health outcomes in people with breast cancer, includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fracture
• Breast Cancer
• Osteopenia
• Osteoporosis

Drugs mentioned

• Anastrozole ( Arimidex ) (anastrozole)
• Exemestane ( Aromasin ) (exemestane)
• Letrozole ( Femara ) (letrozole)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Breast Cancer, Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2012-09-14